Global Blood Therapeutics IPO Research Information

Global Blood Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Global Blood Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Global Blood Therapeutics	GBT - NASDAQ	$16.00-$18.00	$20.00	$34.65	6 million	8/12/2015
Underwriter(s): Morgan Stanley, Goldman Sachs & Co.
Co-Manager(s): Cowen and Company, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2015-07-08 Terms Added 2015-07-31

Global Blood Therapeutics Quote & Chart - Click for current quote - GBT

About Global Blood Therapeutics (adapted from Global Blood Therapeutics prospectus):
They are a biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GBT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.